Botulinum Toxin Stocks List

Botulinum Toxin Stocks Recent News

Date Stock Title
May 10 RVNC Revance Therapeutics, Inc. (NASDAQ:RVNC) Q1 2024 Earnings Call Transcript
May 10 RVNC Revance Therapeutics Reports Q1 2024 Financial Results: Revenue Growth Amidst Rising Operating ...
May 10 URGN UroGen Pharma Q1 2024 Earnings Preview
May 10 EOLS Evolus’ Sandra Beaver Named Orange County Business Journal’s Public Company CFO of the Year
May 10 RVNC Revance Therapeutics Inc. (RVNC) Q1 2024 Earnings Call Transcript
May 9 RVNC Revance Therapeutics, Inc. (RVNC) Reports Q1 Loss, Lags Revenue Estimates
May 9 RVNC Revance Therapeutics GAAP EPS of -$0.58, revenue of $51.94M
May 9 RVNC Revance Reports First Quarter 2024 Financial Results, Provides Corporate Update
May 9 RVNC Revance Expands into the U.S. Therapeutics Market with the Launch of DAXXIFY® for the Treatment of Cervical Dystonia
May 9 AEON AEON Biopharma, Inc. (AEON) Loses -79.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner
May 9 AEON AEON Biopharma Provides Update on Development Pipeline
May 9 EOLS Evolus First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
May 8 RVNC Revance Therapeutics Q1 2024 Earnings Preview
May 8 EOLS Evolus, Inc. (NASDAQ:EOLS) Q1 2024 Earnings Call Transcript
May 8 EOLS Q1 2024 Evolus Inc Earnings Call
May 8 EOLS Evolus Inc (EOLS) (Q1 2024) Earnings Call Transcript Highlights: Strong Growth and Strategic ...
May 8 EOLS Evolus, Inc. (EOLS) Q1 2024 Earnings Call Transcript
May 7 EOLS Evolus, Inc. (EOLS) Reports Q1 Loss, Tops Revenue Estimates
May 7 EOLS Evolus Inc (EOLS) Q1 2024 Earnings: Surpasses Revenue Estimates with Significant Growth
May 7 EOLS Evolus GAAP EPS of -$0.22 in-line, revenue of $59.33M beats by $2.01M
Botulinum Toxin

Botulinum toxin (BTX) is a neurotoxic protein produced by the bacterium Clostridium botulinum and related species. It prevents the release of the neurotransmitter acetylcholine from axon endings at the neuromuscular junction and thus causes flaccid paralysis. Infection with the bacterium causes the disease botulism. The toxin is also used commercially in medicine, cosmetics and research.
Botulinum is the most acutely lethal toxin known, with an estimated human median lethal dose (LD50) of 1.3–2.1 ng/kg intravenously or intramuscularly and 10–13 ng/kg when inhaled.There are eight types of botulinum toxin, named type A–H. Types A and B are capable of causing disease in humans, and are also used commercially and medically. Types C–G are less common; types E and F can cause disease in humans, while the other types cause disease in other animals. Type H is considered the deadliest substance in the world – an injection of only 2 ng can cause death to an adult. Botulinum toxin types A and B are used in medicine to treat various muscle spasms and diseases characterized by overactive muscle. Commercial forms are marketed under the brand names Botox and Dysport, among others.

Browse All Tags